Ultragenyx Settles Dojolvi Patent Litigation With Navinta

Bitget2026/10/19 13:08

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Ultragenyx Pharmaceutical and Baylor Research Institute settled DOJOLVI patent litigation with Navinta on October 19, 2026.
Navinta will receive a non-exclusive, royalty-free license to market generic DOJOLVI beginning January 1, 2033, subject to customary conditions and exceptions.
The launch date would move to July 1, 2033, if DOJOLVI receives pediatric exclusivity.
The litigation stemmed from Navinta's application for FDA approval of a generic version of DOJOLVI oral liquid.
Similar DOJOLVI patent litigation against other generic applicants remains pending in the U.S. District Court for the District of New Jersey.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ultragenyx Pharmaceutical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-424739), on October 19, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

PoolX: Locked for new tokens.

APR up to 10%. Always on, always get airdrop.

Lock now!

At a closed-door Wall Street meeting with ticket prices starting at $7,500 and no media access, U.S. Treasury Secretary Bessent stated that she does not see any “systemic issues” with AI, refuting bubble concerns by saying, “This isn’t Pets.com.” She added that those betting on AI are “the smartest people in the world.” These comments come at a sensitive time as AI stocks have seen multiple bouts of volatility recently.

华尔街见闻•2026/10/22 00:36

BIS closed-door meeting sends message to Wall Street: No signs of “systemic risks” from AI

BUZZ - Shares of Australia's Nova Minerals rise as the U.S. provides funding for the Alaska railroad project

路透社•2026/10/22 00:31

Tail risks before the US midterm elections

新浪财经•2026/10/21 23:53

SAP (SAP.US) Q3 Revenue Surpasses 10 Billion Euros for the First Time; Full-Year Cloud Revenue Expected to Reach the Upper End of Guidance Range

SAP achieved a quarterly revenue milestone by surpassing 10 billions euros in the third quarter, with cloud business growth exceeding expectations, indicating that the artificial intelligence (AI) boom has not diminished market demand for its products. The company also expects its full-year cloud business revenue to reach the upper end of its previously guided range.

智通财经•2026/10/21 23:16